Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
16.25
+0.25 (+1.56%)
Official Closing Price
Updated: 7:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Teva Pharmaceutical Industries ADR
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
FDA Signals Shortage For Teva Pharma's ADHD Drug Due To Manufacturing Delay
October 13, 2022
The FDA said that there was a shortage of Adderall after intermittent manufacturing delays at Teva Pharmaceutical Industries Ltd (NYSE: TEVA).
Via
Benzinga
Teva Under Suspicion On Practices To Stave Off Copaxone Competition
October 10, 2022
The European Commission, in an interim view, says Teva Pharmaceutical Industries Ltd (NYSE: TEVA) breached European Union (EU) antitrust rules over practices delaying competition to the multiple...
Via
Benzinga
European Drug Makers Say Higher Energy Costs Eating Margins: Report
September 27, 2022
Europe's drug makers have warned about stopping manufacturing some cheap generic medicines amid surging electricity costs.
Via
Benzinga
Biden Announces $1.5B To Combat US Overdose Epidemic, Support Recovery
September 23, 2022
Via
Benzinga
Top Financial Media Stories Monday, September 19: Apple iPhone 14's Glitch With Some Third Party Apps, Tesla Wants To Double Sales In Germany, Ford Working On Smartphone Based Crash Detection Tech And More..
September 19, 2022
Reuters Volkswagen Eyes Juicy Valuations For Porsche IPO
Via
Benzinga
Teva To Start Nationwide Settlement Of Opioid Lawsuits From Next Year: Report
September 19, 2022
Via
Benzinga
Teva's Migraine Treatment Effective In Patients With Co-Morbid Depression
September 08, 2022
Via
Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
August 18, 2022
Gainers
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
August 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Sanofi, Children's Place And Some Other Big Stocks Moving Lower On Wednesday
August 17, 2022
Embark Technology, Inc. (NASDAQ: EMBK) fell 25.1% to $12.40. Embark Technology reported the completion of reverse stock split.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate'
August 05, 2022
Following Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) opioid settlement, the Tel Aviv-Yafo, Israel-based company seems to be making “material progress” in clearing its litigation overhangs.
Via
Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
August 17, 2022
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus...
Via
Benzinga
Synaptics To $205? Plus Stifel Cuts Twilio's PT From $200 To This Level
August 05, 2022
Stifel cut the price target for Twilio Inc. (NYSE: TWLO) from $200 to $90. Twilio shares fell 9.6% to $88.75 in pre-market trading.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
August 05, 2022
Upgrades
Via
Benzinga
What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus
August 02, 2022
Analysts have provided the following ratings for Teva Pharmaceutical Indus (NYSE:TEVA) within the last quarter:
Via
Benzinga
Cramer Says This Stock Is Losing Money As 'Too Many Companies Doing The Same Thing'
July 29, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended selling Marqeta Inc (NASDAQ: MQ) adding that "too many companies doing the same thing as they are, and they’re losing money."
Via
Benzinga
Bausch Health (BHC) Stock Plunges 50% on Patent News
July 28, 2022
With Bausch Health losing a critical patent battle enabling its key drug to suffer generic competition, BHC stock veritably crumbled.
Via
InvestorPlace
Allergan To End Around 3,000 Opioid Lawsuits With Over $2B In Settlement: Report
July 28, 2022
Via
Benzinga
PayPal, Alphabet And Some Other Big Stocks Recording Gains On Wednesday
July 28, 2022
U.S. stocks closed sharply higher on Wednesday, with the Dow Jones jumping more than 400 points. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
Most Active Equity Options For Midday - Wednesday, July 27
July 27, 2022
Here are the most active equity options for midday.
Via
Talk Markets
Why This Healthcare Stock Dipped Over 75%; Here Are 73 Biggest Movers From Yesterday
July 28, 2022
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati...
Via
Benzinga
Dow Rises 150 Points As Fed Boosts Rates By 0.75 Percentage Points
July 27, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 150 points on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 27, 2022
Via
Benzinga
Nasdaq Jumps Over 300 Points; Boeing Posts Wider-Than-Expected Loss
July 27, 2022
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 300 points on Wednesday.
Via
Benzinga
TEVA Stock Surges 24% as Teva Pharmaceuticals Settles Lawsuits
July 27, 2022
Teva Pharmaceuticals (TEVA) stock is soaring higher on Wednesday after the pharmaceutical company reached a settlement in recent lawsuits.
Via
InvestorPlace
Why Teva Pharmaceutical Industries Stock Is Soaring
July 27, 2022
Teva Pharmaceutical Industries (NYSE: TEVA) shares are trading higher Wednesday after the company reported better-than-expected financial results.
Via
Benzinga
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
July 27, 2022
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital...
Via
Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
July 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Teva Announces $4.25b Opioid Agreement With States, Native American Tribes
July 27, 2022
Teva has reached an agreement in principle with the working group of States' Attorneys General, counsel for Native American Tribes, and plaintiffs' lawyers representing the States and subdivisions, on...
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.